Fortress Biotech
FBIO
87 hedge funds and large institutions have $101M invested in Fortress Biotech in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 9 closing their positions.
111% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 9
36% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 22
13% more funds holding
Funds holding: 77 → 87 (+10)
0.06% less ownership
Funds ownership: 2.33% → 2.27% (-0.06%)
15% less capital invested
Capital invested by funds: $119M → $101M (-$18M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.74M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.32M |
| 3 |
BlackRock
New York
|
+$462K |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
+$455K |
| 5 |
SC
Sepio Capital
Salt Lake City,
Utah
|
+$389K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2.44M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.09M |
| 3 |
Two Sigma Investments
New York
|
-$503K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$366K |
| 5 |
LPL Financial
San Diego,
California
|
-$321K |
FBIO Hedge Fund Activity: Q4 2020 in Review
87 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q4 2020, worth a combined $101M — down 15% from $119M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new FBIO positions and 9 closed out — a net gain of 10 holders — while 30 added to existing stakes and 22 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.74M. The largest seller was Morgan Stanley, cutting an estimated $2.44M.
- 87 institutional investors held Fortress Biotech (FBIO) as of Q4 2020, up from 77 in Q3 2020.
- Funds reported $101M of Fortress Biotech stock for Q4 2020, down 15% quarter-over-quarter.
- 19 funds opened new Fortress Biotech positions in Q4 2020 and 9 closed out, a net change of +10 holders.
- The largest Fortress Biotech buyer in Q4 2020 was Vanguard Group, an estimated $3.74M added.
- The largest Fortress Biotech seller in Q4 2020 was Morgan Stanley, an estimated $2.44M sold.
Based on aggregated 13F filings for Q4 2020.